Peter is a Senior Research Fellow in the Faculty of Business and Economics at Monash University. He has over ten years of experience evaluating the clinical- and cost-effectiveness of medical technologies for funding on national insurance schemes.  This includes the development of modelled economic evaluations as well as reviews of funded technologies to ensure continued value for money.  His work has directly informed recommendations by the Pharmaceutical Benefits Advisory Committee (PBAC) and Medical Services Advisory Committee (MSAC) in Australia, and the Agency for Care Effectiveness (ACE) in Singapore. 

Other research interests include conducting economic evaluation alongside clinical trials and investigating priority setting in health care.  He is currently undertaking a part-time PhD studying various ways for improving funding decisions by health technology assessment committees, including validating health gains using 'real world' data.